Genetic analysis of RET, GFrα1 and GDNF genes in Spanish families with multiple endocrine neoplasia type 2A

International Journal of Cancer

Volumn 99, Issue 2, 2002, Pages 299-304

  Gil, Laura ^a   Azañedo, Marta ^a   Pollán, Marina ^b   Cristobal, Eva ^c   Arribas, Begoña ^c   García Albert, Luis ^d   García Sáiz, Alfredo ^d   Maestro, María Luisa ^e   Torres, Antonio ^e   Menárguez, Javier ^b   Rojas, José M ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b CARLOS III INSTITUTE OF HEALTH   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

^e HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

GDNF; GFR 1; MEN 2A; Polymorphisms; RET; Spain

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; PROTEIN RET; PROTEIN TYROSINE KINASE;

ARTICLE; DNA POLYMORPHISM; FAMILIAL DISEASE; FISHER EXACT TEST; GENETIC ANALYSIS; HUMAN; MISSENSE MUTATION; ONSET AGE; PEDIGREE; PRIORITY JOURNAL; PROTO ONCOGENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; SIPPLE SYNDROME; SPAIN;

ALLELES; DNA MUTATIONAL ANALYSIS; DROSOPHILA PROTEINS; FEMALE; GENE FREQUENCY; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR RECEPTORS; HUMANS; MALE; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; MUTATION; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; PEDIGREE; POLYMORPHISM, GENETIC; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES; SPAIN;

EID: 0037052762     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10298     Document Type: Article

References (44)

1. Genotype-phenotype correlation in multiple endocrine neoplasia type 2: Report of the International RET Mutation Consortium
2. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A
3. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma
4. Mutations in the RET protooncogene are associated with MEN 2A and FMTC
5. GDNF signaling through the Ret receptor tyrosine kinase
6. Characterization of a multicomponent receptor for GDNF
7. GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF
8. Neurturin, a relative of glial-cell-line-derived neurotrophic factor
9. Persephin, a novel neurotrophic factor related to GDNF and neurturin
10. Artemin, a novel member of the GDNF ligand family, supports peripheral and central neurons and signals through the GFRalpha3-RET receptor complex
11. TrnR2, a novel receptor that mediates neurturin and GDNF signaling through Ret
12. Neurturin responsiveness requires a GPI-linked receptor and the Ret receptor tyrosine kinase
13. A GPI-linked protein that interacts with Ret to form a candidate neurturin receptor
14. GFR alpha-4 and the tyrosine kinase Ret form a functional receptor complex for persephin
15. The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2: International RET mutation consortium analysis
16. Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC
17. Novel germline RET proto-oncogene mutations associated with medullary thyroid carcinoma (MTC): Mutation analysis in Japanese patients with MTC
18. Analysis of RET protooncogene point mutations distinguishes heritable from nonheritable medullary thyroid carcinomas
19. High prevalence of the C634Y mutation in the RET proto-oncogene in MEN 2A families in Spain
20. Mutations of the RET proto-oncogene in Hirschsprung's disease
21. Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease
22. Seminars in medicine of the Beth Israel Hospital, Boston: The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschsprung's disease
23. Genetic predisposition to phaeochromocytoma: Analysis of candidate genes GDNF, RET and VHL
24. Glial cell linederived neurotrophic factor (GDNF) and its receptor (GFR-alpha 1) are strongly expressed in human gliomas
25. The clinical and screening age-at-onset distribution for the MEN-2 syndrome
26. The phenotypes associated with ret mutations in the multiple endocrine neoplasia type 2 syndrome
27. Deletion of genes on chromosome 1 in endocrine neoplasia
28. Human GFRA1: Cloning, mapping, genomic structure and evaluation as a candidate gene for Hirschsprung disease susceptibility
29. Mutation analysis of glial cell line-derived neurotrophic factor (GDNF), a ligand for the RET/GDNF receptor alpha complex, in sporadic phaeochromocytomas
30. Germline mutations of the RET ligand GDNF are not sufficient to cause Hirschsprung disease
31. Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease
32. Analysis of the human GDNF gene reveals an inducible promoter, 3 exons, a triplet repeat within the 3′-UTR and alternative splice products
33. Diverse phenotypes associated with exon 10 mutations of the RET proto- oncogene
34. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction
35. DNA polymorphisms and conditions for SSCP analysis of the 20 exons of the ret proto-oncogene
36. Identification of a polymorphism in exon 11 of the RET protooncogene
37. Over-representation of a germline RET sequence variant in patients with sporadic medullary thyroid carcinoma ana somatic RET codon 918 mutation
38. Mutational analysis of the GDNF/RET-GDNFR alpha signalling complex in a kindred with vesicoureteral reflux
39. Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease
40. Mutation analysis of glial cell line-derived neurotrophic factor, a ligand for an RET/coreceptor complex, in multiple endocrine neoplasia type 2 and sporadic neuroendocrine tumors
41. Two alleles of the human paraoxonase gene produce different amounts of mRNA: An explanation for differences in serum concentrations of paraoxonase associated with the (Leu-Met54) polymorphism
42. Association of RET proto-oncogene codon 45 polymorphism with Hirschsprung disease
43. Specific polymorphisms in the RET proto-oncogene are over-represented in patients with Hirschsprung disease and may represent loci modifying phenotypic expression
44. Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene